暫無數據
代碼股票名稱
最新價漲跌額漲跌幅成交量成交額今開昨收最高最低總市值流通市值總股本流通股本5日漲跌幅10日漲跌幅20日漲跌幅60日漲跌幅120日漲跌幅250日漲跌幅年初至今漲跌幅股息率TTM換手率市盈率TTM市盈率(靜)振幅所屬行業
美股期權個股詳情
INSP240517C110000
- 128.00
- 0.000.00%
延時15分鐘行情收盤價 04/17 09:35 (美東)
0.00最高價0.00最低價
0.00今開128.00昨收0張成交量0張未平倉合約數110.00行權價0.00成交額0.00%引伸波幅47.38%溢價2024/05/17到期日51.49内在价值100合約乘數-5天距到期日76.51時間價值100合約規模美式期權類型--Delta--Gamma1.26槓桿倍數--Theta--Rho--有效槓桿--Vega
分時
- 5日
- 日K
新聞
Inspire Medical Systems, Inc. 將出席傑富瑞全球醫療保健大會
明尼阿波利斯，2024年5月23日（環球新聞專線）——Inspire Medical Systems, Inc.公司（紐約證券交易所代碼：INSP）（Inspire），一家專注於創新微創開發和商業化的醫療技術公司
Inspire Medical Systems（INSP）被奧本海默拒之門外
富國集團維持Inspire Medical Systems(INSP.US)持有評級，維持目標價187美元
富國集團分析師Larry Biegelsen維持$Inspire Medical Systems(INSP.US)$持有評級，維持目標價187美元。根據TipRanks數據顯示，該分析師近一年總勝率為62.3%，總平均回報率為12.1%。提示: TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完
分析師的熱門醫療保健精選：Inspire Medical Systems（INSP）、Cencora（COR）
快訊 | 紐約證券交易所訂單不平衡買入方有51448.0股
暫時保留Inspire Medical（INSP）股票的三個理由
評論
$Inspire Medical Systems(INSP.US$
👎 👉 GHOST NET 👈🗡👊💣👹💰(AWIN - GME - BIG - CTNT - DXYZ - DOGZ - EDBL - HOLO - KOSS - MTC - MGNX - CZOO - TTOO - TUP - CCLD - NVAX - SPWR - SWIN - VFS - WISA ...) BUYERS MUST SELL ALL AND DELETE NOW. THEY BLOCK SHORT, LETS THEY TRAP THEIR STUPID MEMBERS BILLION OF DOLLARS A DAY
👎 🤩🤩🤩😂😂😂
👎 👉 GHOST NET 👈🗡👊💣👹💰(AWIN - GME - BIG - CTNT - DXYZ - DOGZ - EDBL - HOLO - KOSS - MTC - MGNX - CZOO - TTOO - TUP - CCLD - NVAX - SPWR - SWIN - VFS - WISA ...) BUYERS MUST SELL ALL AND DELETE NOW. THEY BLOCK SHORT, LETS THEY TRAP THEIR STUPID MEMBERS BILLION OF DOLLARS A DAY
👎 🤩🤩🤩😂😂😂
Inspire Medical Systems' stock is undervalued, presenting a potential buying opportunity. The company's future looks promising with expected higher cash flow, which should increase share valuation. However, other factors like capital structure should also be considered.
1
Timothy P. Herbert's extensive experience in the medical device industry and deep understanding of the business he founded are expected to enable him to effectively manage the business, execute strategic priorities, and lead the Board.
With strong revenue and growth forecast, Inspire Medical Systems' high P/S ratio appears justified. Analysts concur, with a drop in revenues seeming remote, keeping the share price high.
Dr. Curet's appointment to Inspire Medical Systems' Board will add value as she offers experience in minimal invasive surgery solutions. Her input is anticipated to boost Inspire's treatment for obstructive sleep apnea.
閱讀更多